Introduction
============

Free radicals possess unpaired electrons and are thus defined as molecules or atoms with one or more unpaired electrons. Free radicals are usually unstable and highly reactive. To protect from these highly reactive intermediates, living organisms possess a defense system consisting of both enzymatic and nonenzymatic antioxidants that scavenge them. Nevertheless, under several situations, the rate of generation of reactive oxygen species (ROS) exceeds that of their removal, thus oxidative stress occurs.[@b1-dddt-9-5957] Conditions that bring about oxidative stress caused damage to lipids, proteins, enzymes, carbohydrates, and deoxyribonucleic acid (DNA) in cells and tissues. It has also been known to be associated with pathogenesis of various disorders such as cancer, diabetes, and other age-related diseases.[@b2-dddt-9-5957]

Antioxidants produced internally by the body or externally derived from the diet are compounds that can prevent or slow the oxidative damage to our body and play important roles as prophylactic and therapeutic agents in many diseases.[@b3-dddt-9-5957] Antioxidants act as "free radical scavengers" and hence prevent and repair damage done by these free radicals. Free radical formation is associated with the normal natural metabolism of aerobic cells.

The antioxidant defense system in the body works at a molecular level to protect the cell membrane, lipoproteins, and DNA from the damaging effects of free oxygen radicals.[@b4-dddt-9-5957] Endogenous antioxidants are enzymes that are primarily physiologic in origin; exogenous antioxidants include nutrients and nonnutrients that enter the body through the diet. As a defense mechanism against the toxic ROS, cells are provided with nonenzymatic and enzymatic antioxidants; the former include glutathione (GSH), vitamin E, ascorbic acid, β-carotene, and uric acid. Enzymes involved in antioxidant defenses include superoxide dismutase, catalase (CAT), selenium-dependent glutathione peroxidase (SeGPx), selenium-independent glutathione peroxidase (GPx), alkyl hydroperoxide reductase, glutathione S-transferase, and glutathione reductase.[@b5-dddt-9-5957]

Mushrooms have been used as food for centuries and recently have gained popularity as functional foods and as a source of physiological beneficial medicine. Mushrooms accumulate a variety of secondary metabolites, including phenolic compounds, polyketides, terpenes, and steroids.[@b6-dddt-9-5957] Studies by Wong et al[@b7-dddt-9-5957] and Kho et al[@b8-dddt-9-5957] showed that the ferric-reducing antioxidant power of *Hericium erinaceus* and *Auricularia auricula-judae* mycelia extracts showed good positive correlation with the total phenolic content. Phenolic antioxidants are potent free radical scavengers because they can donate their alcoholic hydrogen atom to free radicals. The antioxidants present in mushrooms are of great interest as protective agents to help the human body, reducing oxidative damage without any interference.[@b9-dddt-9-5957]

*Lentinus squarrosulus* is an edible mushroom commonly found in the wild in Malaysia and has not yet been cultivated on a large scale. It is a white rot saprophytic fungus, which lives on dead or decayed wood in forest. Mushroom mycelia have been reported to be a good source of antioxidants.[@b10-dddt-9-5957] The mycelium of *L. squarrosulus* contains high protein (57.6%) and low total fat (0.5%) and is also rich in magnesium (0.4%), potassium (3.8%), and vitamin B~3~ (0.2%).[@b11-dddt-9-5957] It can be cultivated by liquid fermentation to produce mycelial biomass. Moreover, it is a fast and reliable method for the production of uniform mycelial biomass. Our previous work has shown that *L. squarrosulus* mycelial extract has good antioxidant properties in vitro and it has no toxic effects, even at high doses.[@b11-dddt-9-5957] It is unknown whether the antioxidants can be absorbed and utilized in vivo to lower the risk of chronic diseases. Hence, the aim of this study was to evaluate the bioavailability of *L. squarrosulus* antioxidant extract in vivo by determining the effect on biomarkers of antioxidant defense and oxidative stress.

Materials and methods
=====================

Mushroom samples
----------------

Pure culture of *L. squarrosulus* (KUM50016) was prepared from fresh basidiocarp collected from various forests in Peninsular Malaysia. The basidiocarp of *L. squarrosulus* specimen collected was described and then dried as herbarium specimens. Both dried specimens and pure culture were deposited in Mushroom Research Centre, University of Malaya, Kuala Lumpur, Malaysia.

Preparation of *L. squarrosulus* antioxidant extract
----------------------------------------------------

Mycelium of *L. squarrosulus* was cultured in 500 mL Erlenmeyer flasks containing glucose (1.5%), yeast extract (0.8%), malt extract (0.8%), and peptone (0.8%) liquid medium under static condition at 25°C. After 2 weeks, mycelia broth was harvested and homogenized in water at a ratio of 1:1. The broth was boiled for 30 minutes and centrifuged at 3,000× *g* for 15 minutes. The supernatant was then filtered using Whatman^®^ Grade No 1 filter paper and the water extract was freeze-dried.

Animals
-------

Adult Sprague Dawley rats aged 6--8 weeks and weighing between 180 and 200 g were purchased from Animal House Science Centre, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. The animals were housed at 27°C±2°C temperature and fed with standard laboratory pellet and provided water ad libitum. Experimental protocols were approved by the ethical committee (which follows the guidelines of Animal Care and Use Committee), Laboratory of Animal Science Centre, Faculty of Medicine, University of Malaya (Ethics no: ISB/11/02/2009/NAO(R)).

Assessment of in vivo antioxidant effects of *L. squarrosulus* extract
----------------------------------------------------------------------

A total of 18 male Sprague Dawley rats aged 6--8 weeks were used. The animals were divided randomly into three groups of six animals each namely control group, high-dose and low-dose groups. Control group was given plain drinking water, whereas treated groups were fed with *L. squarrosulus* extracts at two different doses of 250 mg/kg (low-dose group) and 500 mg/kg (high-dose group) per day for 28 days. The animals were maintained according to standard guidelines. Food was given ad libitum. Blood was collected into commercial blood collection tubes (Greiner VACUETTE^®^ Z serum Sep Clot Activator, Greiner Bio-One GmbH, Germany) at day 0 and day 28 for analysis. For each sample, serum was separated from blood by centrifugation at 3,500× *g* for 10 minutes within 2 hours of blood collection and stored at −80°C for analysis. The serum was used to analyze the antioxidant biomarkers using cupric-reducing antioxidant capacity (CUPRAC), glutathione peroxidase (GPx), xanthine oxidase (XO), advanced oxidation protein products (AOPPs), and lipid hydroperoxide (LHP) levels. After 28 days, the rats were sacrificed and the liver samples were excised from the carcass and homogenized using a homogenizer (Ingenieurburo CAT, M. Zipperer GmbH, ShaftT17N, Staufen im Breisgau, Germany) at ratio of 1:10 of liver to ice-cold phosphate buffer solution (PBS). The homogenates were centrifuged at 3,500× *g* for 10 minutes. The resulting supernatants were stored at −80°C for the assessment of GPx and XO.

Analysis of antioxidant activities
----------------------------------

### CUPRAC assay

CUPRAC of 10 μL serum was measured according to the method of Apak et al[@b12-dddt-9-5957] based on the principle of utilizing copper (II)-neocuproine reagent as the chromogenic oxidizing agent. The mixture of 1 mL of copper (II) (1.0×10^−2^ M), neocuproine (7.5×10^−3^ M), ammonium acetate buffer solution (1 M; pH 7), and dH~2~O were added to make a final volume of 4.1 mL. After 30 minutes incubation, the absorbance at 450 nm was measured against a reagent blank. The results of antioxidant activity were expressed as absorbance at 450 nm and compared with ascorbic acid as a positive control.

### GPx activity

All the enzymatic assays were carried out at 25°C using a microplate scanning spectrophotometer and run in triplicate in 96-well microplates. GPx activity was measured by using Glutathione Peroxidase Assay Kit (Cayman Chemical Company, Michigan, USA). The assay was based on glutathione reductase-coupled oxidation of NADPH using hydrogen peroxide as the substrate. One unit of GPx enzyme activity was defined as micromoles of NADPH oxidized per minute per milligram protein.

### Xanthine oxidase activity

Serum and liver XO activity was determined according to the modified method of Singh et al.[@b13-dddt-9-5957] One milliliter of substrate buffer was added with 5 μL of 100 mg/mL uricase and 50 μL sample before incubating at 37°C for 10 minutes. Reagent solution consisting of 2 mM ABTS and 5,000 U/L peroxidase dissolved in 50 mL 66.7 mM phosphate buffer (pH7.9) was mixed well before adding 1 mL of 2 M perchloric acid (HClO~4~). The mixture was centrifuged at 3,500× *g* for 5 minutes. The absorbance of the supernatant was read at 410 nm and the results were expressed as micromoles per milligram proteins.

### AOPP assay

AOPP was determined by the method of Witko-Sarsat et al.[@b14-dddt-9-5957] The premixed reagent containing 81% (w/v) PBS solution, 15% (v/v) of 50% acetic acid, and 4% (w/v) potassium iodide was prepared. This reagent (200 μL) was added into each of the microtiter plate wells that contained 18 μL of the serum samples using eight-channel pipettes. The absorbance of the reaction mixture was immediately read at 340 nm against a blank (water). A series of standards were prepared by adding the premixed reagent to 18 μL of chloramine-T solution (0--500 μmol/L). The chloramine-T absorbance at 340 nm was linear within the range of 0--500 μmol/L. The AOPP concentrations were calculated from the standard curve and were expressed as micromoles per liter of chloramine-T equivalents.

### LHP assay

LHP was measured according to the modified method of Esterbauer and Cheeseman.[@b15-dddt-9-5957] Serum (150 μL) was added to 375 μL 1-methyl-2-phenylindole in acetonitrile and 225 μL HCl (5 M) in a microcentrifuge tube and incubated in a water bath at 45°C for 40 minutes. After centrifugation at 19,600× *g* for 5 minutes, the reaction mixture was read at 586 nm. 1,1,3,3-Tetraethoxypropane was used as a standard at concentrations of 0, 2.5, 5, 10, 15, and 20 μM. The LHP concentrations were calculated from the standard curve and were expressed as micromoles per liter of tetraethoxypropane equivalents.

### Statistical analysis

The results were expressed as mean ± standard error of the mean (SEM), analyzed by SPSS 17.0 (Window 2003; SPSS Inc., Chicago, IL, USA). Differences between groups were tested by one-way analysis of variance. *P*-values less than 0.05 were considered statistically significant. All in vivo antioxidant assays were performed in six replicates.

Results
=======

The CUPRAC level in serum after treatment for 28 days with *L. squarrosulus* mycelium extract in rats with two concentrations, 250 and 500 mg/kg, is shown in [Figure 1](#f1-dddt-9-5957){ref-type="fig"}. Both doses enhanced serum CUPRAC significantly compared to the untreated sample; however, there was no significant difference between low and high doses. Result shows that the cupric-reducing capacity of the *L. squarrosulus* extracts increased along with the increased concentration ([Figure 1](#f1-dddt-9-5957){ref-type="fig"}). GPx activity in serum and liver homogenate is shown in [Figure 2](#f2-dddt-9-5957){ref-type="fig"}. GPx was significantly enhanced in the low-dose treated extract compared to untreated and high dose. The GPx activity in serum between animals treated with both doses of *L. squarrosulus* extract was nonsignificantly different when compared to the control group at day 0. However, GPx activity in serum at low dose was significantly higher compared to the control and high-dose groups after 28 days of treatment. Meanwhile, the GPx activity in liver homogenate at both doses was significantly higher compared to control group after 28 days of treatment ([Figure 2](#f2-dddt-9-5957){ref-type="fig"}). [Figure 3](#f3-dddt-9-5957){ref-type="fig"} shows that XO activity in both serum and liver was significantly decreased compared to the control group. However, in the control group and in the group treated with low dose of extract, the XO level was significantly increased. The level of AOPP in the rats of control group and the rats treated with *L. squarrosulus* at 0 and 28 days is shown in [Figure 4](#f4-dddt-9-5957){ref-type="fig"}. The AOPP level between normal rats and rats treated with the *L. squarrosulus* extract at day 0 was nonsignificant. However, after a treatment period of 28 days with *L. squarrosulus* mycelial extract, the rats treated with high dose showed nonsignificant reduction in AOPP level compared to the control group. The AOPP level in the control group was higher after 28 days compared to day 0. This study showed no significant difference in LHP levels between normal rats and rats treated with the *L. squarrosulus* extract at day 0 ([Figure 5](#f5-dddt-9-5957){ref-type="fig"}). However, after a period of 28 days, the LHP levels were significantly increased in serum of rats after treatment with low-dose *L. squarrosulus* extract, compared with the control group.

Discussion
==========

It is well known that every product that is active in vitro may or may not be active in vivo depending upon its bioavailability. If antioxidants are absorbed and enter the systemic circulation, an increase in the serum antioxidant capacity will occur. The magnitude of the increase is reflected in the amounts of antioxidants absorbed. In this study, the CUPRAC assay was used to monitor absorption, and [Figure 1](#f1-dddt-9-5957){ref-type="fig"} shows that CUPRAC level in serum was significantly elevated in the groups treated with *L. squarrosulus* extract after a period of 28 days. The results showed that the extract caused an increase in the total antioxidant capacity in serum in a dose-dependent manner. Porkkala-Sarataho et al[@b16-dddt-9-5957] reported that long-term administration (between 12 and 36 months) of vitamins C and E alone or in combination at respective daily dosages of 500 and 182 mg was not able to modify the antioxidant capacity of plasma measured using total peroxyl radical trapping. Although the test product was rich in phenolic compounds, mainly anthocyanins, and showed a high antioxidant activity, no significant effect was observed on the antioxidant status or on any biomarkers of oxidative stress (lipid and DNA damage). This *L. squarrosulus* antioxidant extract has high phenolic content of 39.16 mg/100 g and 1,1-diphenyl-2-picrylhydrazyl radical scavenging activity at a half-maximal inhibitory concentration of 14.29 mg/mL.[@b10-dddt-9-5957] Hatano et al[@b17-dddt-9-5957] reported that phenolic compounds are very important constituents and that their radical scavenging ability is due to their hydroxyl groups. The phenolic compounds may contribute directly to the oxidative action.[@b18-dddt-9-5957]

GPx is an enzyme which catalyzes the destruction of peroxides, including hydrogen peroxide, by the oxidation of reduced glutathione. The enzyme is present in mammalian red blood cells and it protects hemoglobin against oxidative breakdown by hydrogen peroxide. It is well established that the enzymes such as CAT and GPx play an important role in protecting red blood cells from the effects of oxidizing agents.[@b19-dddt-9-5957] GPx activity in serum and liver homogenate is depicted in [Figure 2](#f2-dddt-9-5957){ref-type="fig"}. No significant difference in GPx activity was observed in serum between animals treated with high dose of *L. squarrosulus* extract as opposed to low dose when compared to the control group. However, GPx activity in liver homogenate at both doses was significantly higher compared to control group after 28 days of treatment. This correlated with the elevated level of LHP ([Figure 5](#f5-dddt-9-5957){ref-type="fig"}), which could result in increased free radical activity. GPx activity is increased possibly in response to the increase of LHP in an attempt to eliminate it. It shows that the *L. squarrosulus* caused GPx to increase in the liver. Kuppusamy et al[@b20-dddt-9-5957] have showed that GPx activity in human peripheral blood mononuclear cells may be elevated in response to increased availability of H~2~O~2~. The increase in LHP could be due to inevitable stress that occurs when confined. According to Acharya et al,[@b21-dddt-9-5957] *Macrocybe gigantea* basidiocarp extract showed significant increase of GSH, superoxide dismutase, and CAT level in liver and conferred protection against hepatotoxicity induced by CCl~4~ in mice. The possible mechanism may be due to its antioxidant property and ability to scavenge free radicals, which can be correlated to the presence of flavonoid and phenolic compounds.

In humans, XO, a superoxide producing enzyme, is normally found in the liver and not free in the blood. During severe liver damage, XO is released into the blood. This assay was carried out to assess if *L. squarrosulus* mycelial extract can cause harmful effects to the liver after 28 days of treatment. The enzyme XO catalyzes the oxidation of hypoxanthine to xanthine and then to uric acid.[@b22-dddt-9-5957] The suppression of XO in serum and liver implies a reduction in superoxide radical generation. In the presence of liver damage, XO is released into the serum.[@b23-dddt-9-5957] [Figure 3](#f3-dddt-9-5957){ref-type="fig"} shows that after treatment for 28 days with high dose of extract, XO activity was significantly decreased compared to the control group in both serum and liver. However, in the control group and the group treated with low dose of extract, the XO level was significantly increased. This response might be due to stress that occurs when confined. After 28 days of treatment, we observed that the extract of *L. squarrosulus* did not cause any damage to the liver, as activity of enzymes such as alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase did not show significant difference between the treated and control groups (data not shown). Songa et al[@b24-dddt-9-5957] reported that *Phellinus linteus* contains potent antioxidant and that it showed a significant result on inhibition of XO activity. This finding was supported by Nguyen et al[@b25-dddt-9-5957] who showed that antioxidant activities of *Phellinus pini* increased with increasing concentration of the extracts and that XO activity of methanol extract of *P. pini* was as good as allopurinol, a positive control. However, further studies are needed to elucidate relationships between those activities and pharmacological efficacy of mushrooms.

Oxidative damage of proteins was one of the modifications leading to severe failure of biological functions and cell death. Prolonged exposure of protein to reactive molecules leads to spontaneous postsynthetic modifications, such as oxidation to form AOPPs.[@b14-dddt-9-5957] The levels of AOPP in the rats of control group and the rats treated with *L. squarrosulus* at 0 and 28 days are depicted in [Figure 4](#f4-dddt-9-5957){ref-type="fig"}. This study showed no significant difference in oxidative damage of protein between normal rats and the rats treated with the *L. squarrosulus* extract at day 0. However, the animals treated with high-dose extract showed nonsignificant reduction in AOPP level compared to the control group after a period of 28 days. The AOPP level in the control group was higher after 28 days compared to day 0. This might be due to confinement-induced stress. Cakatay et al[@b26-dddt-9-5957] also showed that AOPP levels in the elderly rats were significantly increased compared to the adult rats.

LHPs are lipid peroxidation products formed due to lipid damage. According to Lakshmi et al[@b27-dddt-9-5957] the protective effect of *Ganoderma lucidum*, *Pleurotus florida*, *P. sajor-caju*, and *P. rimosus* extracts significantly inhibited the formation of LHP and thiobarbituric acid-reactive substances leading to membrane damage of organelle from consequent exposure to radiation and to certain chemicals which generate potent ROS in the form of ·OH or ROO· in both rat liver and brain. [Figure 5](#f5-dddt-9-5957){ref-type="fig"} shows that LHP levels were significantly elevated in serum of rats after treatment with low-dose *L. squarrosulus* extract for 28 days, compared to the control group. This might be due to the fact that lipid peroxidation and oxidative protein damage are distinct processes. This finding, supported by Cakatay et al,[@b26-dddt-9-5957] showed an absence of correlation between LHP and oxidative protein damage markers in aging rat muscle tissue due to oxidative stress. However, a higher dose of the extract was more beneficial in attenuating the formation of free LHPs as shown in this study.

Conclusion
==========

In summary, this study clearly showed that *L. squarrosulus* mycelia antioxidant extract contains absorbable antioxidants that enter the circulating plasma and cause a significant acute increase in plasma antioxidant capacity. To the best of our knowledge, this is the first study to evaluate the bioavailability of *L. squarrosulus* mycelial antioxidant extract in vivo by determining the effect on biomarkers of antioxidant defense and oxidative stress. The bioavailable antioxidants can contribute to the beneficial effects of this mushroom. This study also proved that liquid fermentation makes the wild species of *L. squarrosulus* to be a source of antioxidant ingredient for functional foods and nutraceutical industries.
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![CUPRAC levels in serum at 0 and 28 days of treatment under nonoxidative stress condition.\
**Notes:** Mean values with different letters were significantly different (*P*\<0.05) between the control and treated groups. Values expressed are mean ± SEM of six animals. Low dose =250 mg/mL and high dose =500 mg/mL.\
**Abbreviations:** CUPRAC, cupric-reducing antioxidant capacity; SEM, standard error of mean.](dddt-9-5957Fig1){#f1-dddt-9-5957}

![GPx activity in serum at 0 and 28 days and in liver at 28 days of treatment under nonoxidative stress condition.\
**Notes:** Mean values with different letters were significantly different (*P*\<0.05) between the control and treated groups. Values expressed are mean ± SEM of six animals. Low dose =250 mg/mL and high dose =500 mg/mL.\
**Abbreviations:** GPx, glutathione peroxidase; SEM, standard error of mean.](dddt-9-5957Fig2){#f2-dddt-9-5957}

![XO levels in serum at 0 and 28 days and in liver at 28 days, under nonoxidative stress condition in rats.\
**Notes:** Mean values with different letters were significantly different (*P*\<0.05) between the control and treated groups at 0 and 28 days of treatment. Values expressed are mean ± SEM of six animal replicates. Low dose =250 mg/mL and high dose =500 mg/mL.\
**Abbreviations:** XO, xanthine oxidase; SEM, standard error of mean.](dddt-9-5957Fig3){#f3-dddt-9-5957}

![AOPP levels in rats before and after treatment with *Lentinus squarrosulus* under nonoxidative stress condition.\
**Notes:** Mean values with different letters were significantly different (*P*\<0.05) between the control and treated groups. Values expressed are mean ± SEM of six animals. Low dose =250 mg/mL and high dose =500 mg/mL.\
**Abbreviations:** AOPP, advanced oxidation protein product; SEM, standard error of mean.](dddt-9-5957Fig4){#f4-dddt-9-5957}

![LHP levels in serum at 0 and 28 days of treatment under nonoxidative stress condition.\
**Notes:** Mean values with different letters were significantly different (*P*\<0.05) between the control and treated groups. Values expressed are mean ± SEM of six animal replicates. Low dose =250 mg/mL and high dose =500 mg/mL.\
**Abbreviations:** LHP, lipid hydroperoxide; SEM, standard error of mean.](dddt-9-5957Fig5){#f5-dddt-9-5957}
